Signalling mechanisms underlying the myogenic response in human subcutaneous resistance arteries

Citation
P. Coats et al., Signalling mechanisms underlying the myogenic response in human subcutaneous resistance arteries, CARDIO RES, 49(4), 2001, pp. 828-837
Citations number
41
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CARDIOVASCULAR RESEARCH
ISSN journal
00086363 → ACNP
Volume
49
Issue
4
Year of publication
2001
Pages
828 - 837
Database
ISI
SICI code
0008-6363(200103)49:4<828:SMUTMR>2.0.ZU;2-V
Abstract
Objective: In this study we have examined for the first time the signal tra nsduction mechanisms involved in the generation of pressure-dependent myoge nic tone in human small resistance arteries from the subcutaneous vascular bed. Methods: Myogenic responses and the subcellular mechanisms involved in the generation of this response were studied on a pressure myograph. Resul ts and conclusion: Human subcutaneous resistance arteries constricted 14.1/-1.1% in response to an increases in intraluminal, pressure from 40 to 80 mmHg and a further 3.5+/-1.7% in response to the 80-120-mmHg pressure step. Ca2+ depletion or nifedipine abolished this response, whereas BAY K 8644 i ncreased this response to 20.6+/-2.1% (P<0.05, response vs, control). The p hospholipase C inhibitor U-73122 reduced the myogenic response to 2.5+/-1.0 % at 80 mmHg (P<0.001, response vs, control) and abolished it at 120 mmHg. Diacylglycerol lipase inhibition with RHC-80267 abolished all myogenic resp onses to pressure. The protein kinase C (PKC) activator phorbol 12,13-dibut yerate increased the maximal myogenic response to 20.9+/-1.8% (P<0.05, resp onse vs. control), whereas the PKC inhibitor calphostin C abolished myogeni c responses. These data show that the generation of pressure-dependent myog enic tone in human subcutaneous arteries is dependent on Ca2+ influx via vo ltage operated Ca2+ channels (VOCCs) and a concomitant requirement for the activation of phospholipase C (PLC), diacylglycerol, and PKC. (C) 2001 Else vier Science B.V. All rights reserved.